Expression of two such markers ACTA2 and GFAP has been demonstrated in our previous study by using immunohistochemistry.9 The management of hepatic fibrosis still remains a challenge therefore the identification of these proteins and their interacting pathways involved is critical in facilitating early diagnosis and designing target therapeutic modalities.16,17. Here, GFAP is linked to Hepatic fibrosis.